Erudio Healtherudio.com
Sponsor
German CLL Study Group trials: what clinicians said in public
No HCP commentary report on a trial sponsored by German CLL Study Group yet. Erudio has found public clinician commentary on 5 clinical trials sponsored by German CLL Study Group, including CLL12, CLL13, CLL16 and CLL17. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (German CLL Study Group). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CLL17 NCT04608318 · German CLL Study Group DeepView → | previously untreated chronic lymphocytic leukemia | Phase 3 | Deep | View | |||
| CLL13 NCT02950051 · German CLL Study Group DeepView → | previously untreated CLL without del(17p) or TP53 mutation | Phase 3 | Deep | View | |||
| CLL12 NCT02863718 · German CLL Study Group DeepView → | untreated Binet stage A CLL with progression risk | Phase 3 | Deep | View | |||
| CLL16 NCT05197192 · German CLL Study Group DeepView → | previously untreated high-risk chronic lymphocytic leukemia | Phase 3 | Deep | View | |||
| CLL2-BZAG NCT04515238 · German CLL Study Group FocusedView → | relapsed/refractory CLL | Phase 2 | Focused | View | |||